Akdital is pressing ahead with its ambitious growth strategy, announcing the opening of several new healthcare facilities in 2025 across Casablanca, Laâyoune, Guelmim, Inzegane, Rabat, Nador, and Oujda. With a target of surpassing 54 clinics in more than 30 cities by 2026, the group is strengthening its nationwide presence to meet the rising demand for quality healthcare. This rapid expansion is backed by solid financial foundations, particularly following a successful capital increase in July 2024.
The past year has been a milestone for Akdital, with 12 new facilities added to its network, bringing the total number of clinics to 33 and increasing its capacity to 3,706 beds. The group has expanded into several strategic locations, including Tétouan, Dakhla, Kénitra, Meknès, Khouribga, Benguérir, Essaouira, Marrakech, Errachidia, and Taroudant. This continued growth underscores Akdital’s commitment to ensuring access to high-quality medical services across Morocco.
Innovation remains a key focus, with the integration of cutting-edge medical technologies, such as a surgical robot, and the launch of Akdital Innov, a center of excellence dedicated to advanced healthcare solutions.
Financially, Akdital delivered a strong performance in 2024, recording revenues of 2.95 billion dirhams—up 55% from the previous year. Oncology has become an increasingly significant segment, now contributing 33% of total revenue compared to 31% in 2023.
The group also saw a sharp rise in profitability, with EBITDA reaching 839 million dirhams, a 64% increase, and consolidated net income growing by 76% to 348 million dirhams. This growth is attributed to strict cost management and the rapid operational ramp-up of new facilities.
To support its expansion, Akdital invested 1.79 billion dirhams in 2024—64% more than the previous year—allocating funds to equip new facilities and prepare for upcoming openings in 2025 and 2026.
Despite this aggressive investment strategy, the group has maintained prudent financial management, with net debt standing at 1.75 billion dirhams and a debt-to-EBITDA ratio improving from 2.4 to 2.0, reflecting a controlled and sustainable growth trajectory.
In light of these strong results, the Board of Directors will propose a dividend payout of 10 dirhams per share at the next General Assembly, reaffirming Akdital’s commitment to rewarding its shareholders while continuing its expansion.
With a goal of reaching 54 healthcare facilities across 30+ cities by 2026, Akdital is positioning itself as a major force in Morocco’s evolving healthcare landscape. Its robust project pipeline and ability to execute on schedule validate the strength of its strategy.
“We faced a significant challenge this year in delivering all 12 planned openings on time, honoring our commitments to both patients and partners,” said Rochdi Talib, Chairman and CEO of Akdital. “Our successful capital increase in 2024 now provides us with the resources to accelerate our expansion and reinforces our mission to provide quality healthcare access to all Moroccans.”
